• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Occult HBV infection status and its impact on surgical outcomes in patients with curative resection for HCV-associated hepatocellular carcinoma.丙型肝炎病毒相关肝细胞癌根治性切除患者的隐匿性乙型肝炎病毒感染状况及其对手术结局的影响
Hepatobiliary Surg Nutr. 2018 Dec;7(6):443-453. doi: 10.21037/hbsn.2018.10.01.
2
Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma.隐匿性乙型肝炎病毒感染与非B、非C型肝细胞癌根治性切除患者的手术结局
World J Hepatol. 2017 Dec 18;9(35):1286-1295. doi: 10.4254/wjh.v9.i35.1286.
3
Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.隐匿性乙型肝炎病毒感染对慢性丙型肝炎结局的影响。
J Hepatol. 2013 Oct;59(4):696-700. doi: 10.1016/j.jhep.2013.05.043. Epub 2013 Jun 7.
4
Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.丙型肝炎病毒相关性肝细胞癌中隐匿性乙型肝炎病毒感染的临床病理研究
Eur J Gastroenterol Hepatol. 2019 Jun;31(6):716-722. doi: 10.1097/MEG.0000000000001388.
5
Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.摩洛哥隐匿性乙肝病毒感染:从慢性肝炎到肝细胞癌
Liver Int. 2014 Jul;34(6):e144-50. doi: 10.1111/liv.12482. Epub 2014 Mar 11.
6
Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area.非肝硬化性肝细胞癌:乙肝病毒流行地区的病因及隐匿性乙肝病毒感染
Therap Adv Gastroenterol. 2017 Jul;10(7):529-536. doi: 10.1177/1756283X17710247. Epub 2017 May 22.
7
Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.隐匿性乙型肝炎病毒感染与慢性丙型肝炎病毒感染的疾病进展无关。
World J Gastroenterol. 2016 Nov 14;22(42):9427-9436. doi: 10.3748/wjg.v22.i42.9427.
8
Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.日本肝癌患者中隐匿性乙型肝炎感染的频率和特征。
Ann Hepatol. 2018;17(4):596-603. doi: 10.5604/01.3001.0012.0927.
9
Impact of occult hepatitis B virus infection on outcome after resection for non-B non-C hepatocellular carcinoma.隐匿性乙型肝炎病毒感染对非乙型肝炎非丙型肝炎肝细胞癌切除术后结局的影响。
J Surg Res. 2015 Jan;193(1):153-60. doi: 10.1016/j.jss.2014.07.021. Epub 2014 Jul 21.
10
Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients.慢性丙型肝炎患者隐匿性乙型肝炎病毒感染和扭转型肠病毒感染的流行情况及其与肝细胞癌的关系。
Virus Res. 2017 Oct 15;242:166-172. doi: 10.1016/j.virusres.2017.09.022. Epub 2017 Sep 29.

本文引用的文献

1
Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma.隐匿性乙型肝炎病毒感染与非B、非C型肝细胞癌根治性切除患者的手术结局
World J Hepatol. 2017 Dec 18;9(35):1286-1295. doi: 10.4254/wjh.v9.i35.1286.
2
Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas.较高体重指数对乙型和丙型肝炎相关肝细胞癌的影响。
Langenbecks Arch Surg. 2017 Aug;402(5):745-755. doi: 10.1007/s00423-017-1589-2. Epub 2017 May 22.
3
Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up.隐匿性乙型肝炎对慢性丙型肝炎病毒感染患者临床结局的影响:一项 10 年随访研究。
J Formos Med Assoc. 2017 Sep;116(9):697-704. doi: 10.1016/j.jfma.2016.11.002. Epub 2016 Dec 21.
4
Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.隐匿性乙型肝炎病毒感染与慢性丙型肝炎病毒感染的疾病进展无关。
World J Gastroenterol. 2016 Nov 14;22(42):9427-9436. doi: 10.3748/wjg.v22.i42.9427.
5
Update on occult hepatitis B virus infection.隐匿性乙型肝炎病毒感染的最新进展。
World J Gastroenterol. 2016 Oct 21;22(39):8720-8734. doi: 10.3748/wjg.v22.i39.8720.
6
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.HBsAg阴性患者肝癌和肝硬化组织中的隐匿性HBV感染:一项病毒学和临床研究。
Oncotarget. 2016 Sep 20;7(38):62706-62714. doi: 10.18632/oncotarget.10909.
7
Occult hepatitis B virus infection: influence of S protein variants.隐匿性乙型肝炎病毒感染:S蛋白变体的影响
Virol J. 2016 Jan 19;13:10. doi: 10.1186/s12985-016-0464-z.
8
Role of occult hepatitis B virus infection in chronic hepatitis C.隐匿性乙型肝炎病毒感染在慢性丙型肝炎中的作用。
World J Gastroenterol. 2015 Nov 14;21(42):11931-40. doi: 10.3748/wjg.v21.i42.11931.
9
Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.2009年日本的癌症发病率及发生率:针对日本癌症发病率监测(MCIJ)项目的32个基于人群的癌症登记处的研究。
Jpn J Clin Oncol. 2015 Sep;45(9):884-91. doi: 10.1093/jjco/hyv088. Epub 2015 Jul 3.
10
Occult hepatitis B virus and hepatocellular carcinoma.隐匿性乙型肝炎病毒与肝细胞癌
World J Gastroenterol. 2014 May 28;20(20):5951-61. doi: 10.3748/wjg.v20.i20.5951.

丙型肝炎病毒相关肝细胞癌根治性切除患者的隐匿性乙型肝炎病毒感染状况及其对手术结局的影响

Occult HBV infection status and its impact on surgical outcomes in patients with curative resection for HCV-associated hepatocellular carcinoma.

作者信息

Yamaji Koutaro, Kai Keita, Komukai Sho, Koga Hiroki, Ide Takao, Kawaguchi Atsushi, Noshiro Hirokazu, Aishima Shinichi

机构信息

Department of Surgery, Saga University Faculty of Medicine, Saga 849-8501, Japan.

Department of Pathology & Microbiology, Saga University Faculty of Medicine, Saga 849-8501, Japan.

出版信息

Hepatobiliary Surg Nutr. 2018 Dec;7(6):443-453. doi: 10.21037/hbsn.2018.10.01.

DOI:10.21037/hbsn.2018.10.01
PMID:30652089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6295390/
Abstract

BACKGROUND

We sought to clarify the prevalence of occult hepatitis B virus (HBV) infection (OBI) and to determine whether OBI affects the surgical outcomes in curatively resected Japanese patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).

METHODS

A total of 257 patients with HCV-related HCC who underwent curative surgical resection were enrolled. All enrolled patients were serologically negative for HBV surface antigen and positive for HCV antibody. DNA was extracted from formalin-fixed paraffin-embedded liver tissue. OBI was determined by the HBV-DNA amplification of at least two different sets of primers by TaqMan real-time polymerase chain reaction. Surgical outcomes were evaluated according to overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS).

RESULTS

OBI was identified in 15 of the 257 (5.8%) cases. In the multivariate analyses, the factors significantly correlated with OS were BMI >25 (P=0.0416), portal vein invasion (P=0.0065), and multiple tumors (P=0.0064). The only factor significantly correlated with DSS was T-stage (P=0.0275). The factors significantly correlated with DFS were liver fibrosis (P=0.0017) and T-stage (P=0.0001). The status of OBI did not show any significant correlation with OS, DSS or DFS, but a weak association with DSS (P=0.0603) was observed.

CONCLUSIONS

The prevalence of OBI was 5.8% in 257 cases of HCV-related HCC. Although a weak association between DSS and OBI was observed, and statistical analyses were limited by small number of OBI cases, no significant correlation between OBI and surgical outcomes was detected.

摘要

背景

我们试图阐明隐匿性乙型肝炎病毒(HBV)感染(OBI)的患病率,并确定OBI是否会影响日本丙型肝炎病毒(HCV)相关肝细胞癌(HCC)患者手术切除后的疗效。

方法

共纳入257例行根治性手术切除的HCV相关HCC患者。所有纳入患者的HBV表面抗原血清学检测均为阴性,HCV抗体检测均为阳性。从福尔马林固定石蜡包埋的肝组织中提取DNA。采用TaqMan实时聚合酶链反应,通过至少两组不同引物的HBV-DNA扩增来确定OBI。根据总生存期(OS)、疾病特异性生存期(DSS)和无病生存期(DFS)评估手术疗效。

结果

257例患者中有15例(5.8%)被诊断为OBI。在多因素分析中,与OS显著相关的因素为体重指数>25(P=0.0416)、门静脉侵犯(P=0.0065)和多发肿瘤(P=0.0064)。与DSS显著相关的唯一因素为T分期(P=0.0275)。与DFS显著相关的因素为肝纤维化(P=0.0017)和T分期(P=0.0001)。OBI状态与OS、DSS或DFS均无显著相关性,但观察到与DSS有较弱的关联(P=0.0603)。

结论

在257例HCV相关HCC患者中,OBI的患病率为5.8%。尽管观察到DSS与OBI之间存在较弱的关联,且由于OBI病例数量较少,统计分析受到限制,但未检测到OBI与手术疗效之间存在显著相关性。